Literature DB >> 30274116

Synthesis, characterization and synergistic activity of cerium-selenium nanobiocomposite of fungal l-asparaginase against lung cancer.

G Baskar1, K Lalitha2, R Aiswarya2, R Naveenkumar2.   

Abstract

Cerium selenium nanobiocomposites are novel lung cancer drug as they possess combined anti-cancer property of nanocomposite with l-asparaginase working in synergetic manner. Cerium selenium nanobiocomposites were synthesized using simple co-precipitation method. The size of the nanocomposite was found to be in the range 60-90 nm. Maximum absorption was observed using UV spectrum in the range of 350-490 nm. The nanobiocomposites was characterized using H-NMR and FTIR analysis it was found that secondary alkyl, allylic carbon, monosubstituted alkenes and sp2 hybridized CH bonds of alkenes were involved in binding of cerium and selenium nanoparticles with l-asparaginase for the formation of cerium selenium nanobiocomposite. The spherical shape of the cerium selenium nanobiocomposites were confirmed using SEM. Anticancer activity was checked by performing MTT assay resulting in 70.84% and 48.78% toxicity for maximum concentration of 1000 (μg/ml) and IC50 concentration of 125 (μg/ml) respectively on A549 lung cancer cell line using fluorescent microscopic analysis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  A549 cell line; Asparaginase; Cerium selenium nanobiocomposite; MTT assay; Novel lung cancer drug

Mesh:

Substances:

Year:  2018        PMID: 30274116     DOI: 10.1016/j.msec.2018.08.051

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  7 in total

1.  Molecular cloning, characterization, and in-silico analysis of l-asparaginase from Himalayan Pseudomonas sp. PCH44.

Authors:  Subhash Kumar; Sanyukta Darnal; Vijeta Patial; Virender Kumar; Vijay Kumar; Sanjay Kumar; Dharam Singh
Journal:  3 Biotech       Date:  2022-07-09       Impact factor: 2.893

Review 2.  Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy.

Authors:  Yingbo Li; Jie Yang; Xilin Sun
Journal:  Front Chem       Date:  2021-04-22       Impact factor: 5.221

Review 3.  Recent Strategies and Applications for l-Asparaginase Confinement.

Authors:  João C F Nunes; Raquel O Cristóvão; Mara G Freire; Valéria C Santos-Ebinuma; Joaquim L Faria; Cláudia G Silva; Ana P M Tavares
Journal:  Molecules       Date:  2020-12-10       Impact factor: 4.411

Review 4.  Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents.

Authors:  Akmal M Asrorov; Bahtiyor Muhitdinov; Bin Tu; Sharafitdin Mirzaakhmedov; Huiyuan Wang; Yongzhuo Huang
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

5.  Biochemical and Biological Evaluation of an L-Asparaginase from Isolated Escherichia coli MF-107 as an Anti-Tumor Enzyme on MCF7 Cell Line

Authors:  Masoumeh Shahnazari; Razieh Bigdeli; Aziz Dashbolaghi; Reza Ahangari Cohan; Alireza Shoari; Hossein Hosseini; Davoud Nouri Inanlou; Vahid Asgary
Journal:  Iran Biomed J       Date:  2022-07-01

Review 6.  Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers.

Authors:  Shruti Rawal; Mayur Patel
Journal:  Nanomicro Lett       Date:  2021-06-12

7.  Targeted Delivery of Chlorin e6 via Redox Sensitive Diselenide-Containing Micelles for Improved Photodynamic Therapy in Cluster of Differentiation 44-Overexpressing Breast Cancer.

Authors:  Chan Feng; Donglei Zhu; Lv Chen; Yonglin Lu; Jie Liu; Na Yoon Kim; Shujing Liang; Xia Zhang; Yun Lin; Yabin Ma; Chunyan Dong
Journal:  Front Pharmacol       Date:  2019-04-16       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.